HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Studying Probiotic Strain For Infant Dermatitis

Executive Summary

J&J Consumer in partnership with Infinant Health is conducting a prospective clinical trial to assess the immunological effect of supplementation with probiotic strain bifidobacterium infantis EVC001 in healthy breastfed infants at risk of developing atopic dermatitis.

You may also be interested in...



Nestlé Discovers Gut Bacteria Strain Suggesting Opportunities For Infant Nutrition

Scientists at Nestlé’s research division think that they have found new bifidobacterium longum strains that have unique ability to utilize both key components of human milk and fibers from solid food, opening up new opportunities for “next generation nutritional solutions” like probiotics targeting the crucial weaning period of child development.

Over The Counter 26 Sept 2023: Disrupting the Consumer Health Industry, With Maxwellia’s Anna Maxwell

In this episode, HBW Insight catches up with UK switch specialists Maxwellia to find out what’s next for the company that gave to the UK one of the first OTC daily contraceptive pills. Now a disruptive consumer health player in its own right, the company is looking for investors to take it to the next level and help launch two new women’s health products in the pipeline for next year, CEO Anna Maxwell reveals in this exclusive interview.

Offset-Based Green Claims Like 'Carbon Neutral' Will Soon Be Banned In Europe

The Green Claims Directive has moved one step closer to becoming European Union law. Once passed, within 24 months CO2 offset-based claims like "carbon neutral" will be banned altogether, claims like “environmentally friendly” will require substantive backing and sustainability labels in general will need to be approved beforehand by certification schemes or public authorities. 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153406

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel